Russia’s Vektor Reports Success with Phase I Trial of HIV Vaccine
This article was originally published in PharmAsia News
Executive Summary
A Russian government research group reported successful Phase I clinical trials of an HIV vaccine capable of producing a strong antigen and cellular response to the disease.